肝多房棘球蚴病的手术治疗进展  

Advances in surgical treatment of hepatic alveolar echinococcosis

作　　者：祖力皮喀尔·图孙尼亚孜 蒋铁民[1] 温浩[1] ZULIPIKAER Tusunniyazi;JIANG Tiemin;WEN Hao(The First Affiliated Hospital of Xinjiang Medical University,Urumqi 830000,Xinjiang,China)

机构地区：[1]新疆医科大学第一附属医院,新疆乌鲁木齐830000

出　　处：《中国寄生虫学与寄生虫病杂志》2024年第6期783-789,共7页Chinese Journal of Parasitology and Parasitic Diseases

基　　金：新疆维吾尔自治区重点实验室开放课题基金(2021D04024)。

摘　　要：肝多房棘球蚴病(HAE)是一种人兽共患病,在我国主要流行于新疆、青海、西藏、四川等地区。HAE可造成严重且不可逆的损伤,严重影响人体健康和地区经济,其防治工作仍然是国家疾病预防控制工作的重点之一。根治性肝切除术是目前治疗HAE的首选方法,难以根治性切除的晚期HAE可行姑息性手术、介入治疗、肝移植术等治疗手段。本文就HAE的治疗现状和最新进展作一综述。Hepatic alveolar echinococcosis(HAE)is a zoonotic disease.It is predominantly found in regions such as Xinjiang,Qinghai,Xizang and Sichuan in China.HAE can cause severe and irreversible damage,and significantly impacting human health and regional economies.The prevention and control of HAE remains a key focus of national disease prevention and control efforts.Radical surgical resection is the preferred treatment for HAE;while palliative surgery and liver transplantation are alternative options for late-stage HAE cases radical resection is not suitable.This article provides an overview of the current treatment status and latest advancements in the management of HAE.

关 键 词：肝多房棘球蚴病 手术治疗 治疗进展 

分 类 号：R532.32[医药卫生—内科学]